🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

REPO4EU 💬Quote from #iDR24 Cancer path💬 “Clinical trials are very expensive. We need clever clinical trial design, e.g. risk-adapted trials. #DrugRepurposing trials may need a little bit more [financial] support." - Ruth Langley (MRC Clinical Trials Unit at UCL)

While the #iDR24 event has formally closed, the #REMEDi4ALL Funders Network are staying in Barcelona to discuss the next steps for the funders in the drug repurposing journey. 👉Find out more about the network here: remedi4all.org/funders-networ…

In today’s Brioches Club, I will be presenting the amazing work of Berend Snijder and his team, who use Pharmacoscopy to identify repurposable neuroactive drugs for #glioblastoma treatment. Mind blowing stuff! 🤯 biorxiv.org/content/10.110…

Thank you Pan Pantziarka Pan Pantziarka for discussing drug repurposing at #ESMOSarcomaAndRareCancers24 in #Lugano. Thank you also for advancing drug repurposing in #EHE #epithelioidhemangioendothelioma #EHEresearch #EHEawareness #EHEcancer #sarcoma

We are at the ESMO sarcoma and rare cancers Annual Congress. ✅#rarecancers is a priority focus in our research programs, because more treatments are urgently needed. ✅#sarcomas are difficult cancers to understand and to treat, so more funding is necessary. #anticancerfund

There's still time to sign up for our 'TP53 – Harnessing research and practice for patient benefit in Li Fraumeni Syndrome (LFS)' symposium! If you are a researcher or clinician working on LFS-related projects in the UK, join us ⬇️ Medical Sciences

What is a Sarcoma Specialist Center? Two years of consultation and discussion between SPAGN and CTOS to achieve an important consensus. Welcome to the world of the Sarcoma Intelligent Specialist Network. #sarcomacenters mdpi.com/2072-6694/16/1…

Rare cancers represent 20% of all new cancer diagnoses, but are under-researched. By funding international, collaborative clinical trials, we aim to stimulate the development of better drug therapies in Europe. anticancerfund.org/news/internati… #anticancerfund #rarecancers #cancerresearch

Excellent paper inc. beautiful illustration of how increased WGS availability is leading to unexpected cancer predisposition diagnosis Up to 1 in 5 #sarcoma assoc w genetic predisposition-urgent need to understand clinical implications &how to manage Silvia Stacchiotti Kjetil Boye

A 100-year-old drug might be a promising treatment for autism spectrum disorder! A small clinical trial recently revealed that Suramin, a drug originally developed for African sleeping sickness, seems to improve communication skills and social behaviors in individuals with

Are you a Master's student with excellent CV in cancer bioinformatics who is about to defend or recently defended? Would like to do a PhD in the Nordics on cancer network modeling? I have an opportunity with tight deadline. Email your CV and motivation: med.uio.no/ncmm/english/p…

Proud to have contributed to this article. A must read for policymakers, as this explains why the revision of the EU pharmaceutical legislation is essential for #drugrepurposing, an innovative strategy to find new treatments. #anticancerfund @remedi4all Pan Pantziarka

ANZUP Christopher Steer Anticancer Fund Hunter Medical Research Institute (HMRI) LUMC Leiden Cancer Australia Ian Davis Laurence E M Krieger

Osteosarcoma, an aggressive bone cancer, most commonly affects children and young adults. New research solves the mystery of what drives the genomic rearrangements causing the aggressive development and evolution of osteosarcoma tumours. ebi.ac.uk/about/news/res…

Please do read our letter to editor to Journal of Clinical Oncology with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms? Congratulations Abhenil Mittal for raising awareness re this important issue. ascopubs.org/doi/10.1200/JC…

🧵While much of the burgeoning interest in oncological repurposing is related to a few very high profile candidates, such as aspirin or metformin, there is a wide range of non-cancer drugs which have some level of anticancer activity Pan Pantziarka ecancer.org/en/journal/art…

🎥Check out our new video on #DrugRepurposing! By building on what we know about a drug's safety & effectiveness, drug repurposing is accelerating the journey from lab to patient. Watch our video below to learn more, & visit 👉 remedi4all.org

It's fantastic to have Pancreatic Cancer UK, The Brain Tumour Charity and Brain Tumour Research all helping to shape my Private Member's Bill on rare cancers. The vote is on the 14th of March. Evening News article- edinburghnews.scotsman.com/news/edinburgh…

Last call! Register now for our first webinar on Clinical Trials this Friday 21 Feb! Join us for an introduction on clinical trials with clinical trial experts at ECRIN, joined by Beacon and EURORDIS! Interested in learning more? Register now! ➡️ loom.ly/9Z_WJbg

The euthanasia committee rejected an amendment to ensure people being killed by the state have “met with a palliative care specialist for the purposes of being informed about the medical and care support options." This is not about choice; it is about cost-cutting. Evil.